Arthroscopic Shoulder Surgery With Administration of Intravenous Tranexamic Acid
Status:
Completed
Trial end date:
2018-02-28
Target enrollment:
Participant gender:
Summary
Purpose: The study aimed to determine whether intravenous administration of tanexamic acid
(TXA) before shoulder arthroscopic rotator cuff repair surgery can improve arthroscopy visual
clarity. Methods: This is a prospective, double-blinded, randomized and placebo-controlled
study. From May 2016 to April 2018, patients requiring arthroscopic rotator cuff repair were
enrolled and randomly assigned to either the TXA group that received 1000mg tranexamic acid
intravenously 10 minutes before surgery or the placebo group that received the same volume of
plain saline. Patients with pre-existing liver/renal disease, coagulopathy, or concurrent use
of anti-coagulation medications were excluded. The visual clarity was rated by a numeric
rating scale from grade
1(poor) to grade 3(clear) every 15 minutes throughout the surgery. Secondary outcomes
included estimated perioperative blood loss, operative time, degree of shoulder swelling,
postoperative subjective pain score, inpatient duration and associated comorbidities were
recorded. Both parametric and nonparametric methods were used for statistical analysis.